Try our Advanced Search for more refined results
Searching dockets in Aratana Therapeutics Inc x
Alert me of new activity
All Case Activity Alerts Include: Answers, Appeals, Complaints, Motions, Orders, Trial Notes
Securities/Commodities | New York Southern
Memo Endorsement ~Util - Terminate Motions
MEMO ENDORSEMENT on re: 16 Notice (Other), filed by Joseph Pierson, Motions terminated: 10 MOTION to Strike Document No. 5 Plaintiff's Motion for An Award of Attorneys' Fees and Expenses, Or, in the Alternative, for Extension of Time to Respond to Plaintiff's Motion. filed by Craig A. Barbarosh, Irvine O. Hockaday, Jr., J.D., Aratana Therapeutics, Inc., John W. Vander Vort, J.D., Craig Tooman, Merilee Raines, Lowell W. Robinson, David L. Brinkley, Robert P. Roche, Jr., Wendy Yarno, 5 MOTION for Attorney Fees . filed by Joseph Pierson. ENDORSEMENT: Application granted. The Clerk of Court is respectfully directed to terminate items 5 and 10 on the docket. SO ORDERED. (Signed by Judge Ronnie Abrams on 11/24/2020) (kv)
Notice (Other)
NOTICE of WITHDRAWAL OF HI MOTION FOR AN AWARD OF ATTORNEYS FEES AND EXPENSES re: 6 Memorandum of Law in Support of Motion, 8 Proposed Order, 5 MOTION for Attorney Fees ., 7 Declaration in Support of Motion,. Document filed by Joseph Pierson..(Monteverde, Juan)
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login
Email (NOTE: Free email domains not supported)
First Name
Last Name
Job Title
PLEASE NOTE: A verification email will be sent to your address before you can access your trial.
Password (at least 8 characters required)
Confirm Password
Law360 may contact you in your professional capacity with information about our other products, services and events that we believe may be of interest.You’ll be able to update your communication preferences via the unsubscribe link provided within our communications.We take your privacy seriously. Please see our Privacy Policy.